Health Sciences | Penn Today

Recovery Pool at Penn Vet's New Bolton Center Gives Horses a Leg Up After Surgery

KENNETT SQUARE — Horses weigh more than half a ton and can sleep standing up, so as surgical patients, they can’t recuperate in a cushy bed.

Penn Med-led Cardiovascular Health Screening Technology Receives Development Funding From AHA

The American Heart Association (AHA) announced today that they have made their first investment through the Science & Technology Accelerator Program into CytoVas, LLC. The company was founded by Jonni S.

Penn Receives $25 Million Gift to Create Basser Research Center for Inherited Cancers

PHILADELPHIA — A $25 million gift to the University of Pennsylvania from alumni Mindy and Jon Gray will establish a center focused on the treatment and prevention of cancers associated with hereditary BRCA mutations.

Penn Vet’s Field Service Tends to the Farms

KENNETT SQUARE — It’s a quaint image: a rural vet in a pick-up truck driving down a country lane to treat a sick cow or horse.

Block Its Recycling System, and Cancer Kicks the Can, According to New Penn Study

All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments.

Penn’s Steve Fluharty Has a Hand in the “Golden Goose” Awards Highlighting Basic Research

PHILADELPHIA -- Steve Fluharty, the University of Pennsylvania’s senior vice provost for research, is participating in a new congressional program that will highlight federally funded science projects.

Liver Fat Gets a Wake-Up Call That Maintains Blood Sugar Levels, According to Penn Study

A Penn research team, led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism at the Perelman School of Medicine, University of Pennsylvania, repor

NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

Penn’s Center for High Impact Philanthropy Launches Development of Child-Survival Tool Kit for Donors

Each year, before reaching age age 5, almost 8 million children die from preventable causes.

Genetically Modified T Cell Therapy Shown to Be Safe, Lasting in Penn Medicine Study of HIV Patients

HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine.

Filters